New biotech venture fund debuts with $300M for a mix of US and European players
There’s another new biotech venture fund in play. And this one is launching with an experienced venture player at the helm and a clear mission …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
